Pall Corporation (www.pall.com), a manufacturer of filtration, separation and purification technology acquired GeneSystems (www.genesystems.fr), a privately held French biotechnology company that has developed what Pall describes as a “cost-effective” molecular diagnostics platform.
The acquisition of GeneSystems, with its patented approach to rapid microbiological detection equipment and disposables, is intended to expand Pall’s Total Fluid Management (TFM) platform in biopharmaceuticals process monitoring market. The acquisition is also expected to present Pall with new opportunities in its environmental, food and beverage and water markets.
Process monitoring includes the analytical tests required during biopharmaceuticals manufacturing for environmental monitoring, in-process control testing and finished product release testing. These tests are receiving increased regulatory scrutiny and support under initiatives such as Process Analytical Technology (PAT).